Back to News
Market Impact: 0.15
Voyager Appoints Robin Swartz As President, CEO Transition Expected In Q1 2027; Stock Down
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Voyager Therapeutics appointed Robin Swartz president, effective October 20, 2026. The announcement provided no further details on the appointment or its expected impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
VYGR0.10
More News
- Elon Musk Thinks $3.5 Trillion Tesla-SpaceX Mashup Is a Good Idea
- Zuckerberg told Meta directors he might leave California, where he could lose billions to a wealth tax. Meta answered with a new class of stock
- Sovereign wealth funds' China and Hong Kong investments surge 190% after a bruising slump
- This wonky maneuver kept Mark Zuckerberg from fleeing a California billionaire tax
- Meta wants to pay for its broad AI buildout with a newly created class of stock
- Meta stock surges on strong earnings report; tech giant unveils new shares to bankroll AI spending